Home  |  Contact

Cellosaurus COG-E-352 (CVCL_M153)

Cell line name COG-E-352
Synonyms CHLA-352; CHLA352; COGE352
Accession CVCL_M153
Resource Identification Initiative To cite this cell line use: COG-E-352 (RRID:CVCL_M153)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: MD Anderson Cell Lines Project.
Doubling time: 28 hours (PubMed=24312454).
Omics: Deep exome analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: Transcriptome analysis by RNAseq.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Sequence variations
  • Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
  • Gene fusion; HGNC; 3446; ERG + HGNC; 3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=25010205).
  • Mutation; HGNC; 11355; STAG2; Simple; p.Leu791fs; Zygosity=Unspecified (PubMed=25010205; DepMap).
  • Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=25010205; DepMap).
Disease Primitive neuroectodermal tumor (NCIt: C3716)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 17Y
Category Cancer cell line
STR profile Source(s): PubMed=24312454; PubMed=25010205

Markers:
AmelogeninX,Y
CSF1PO10,11
D2S133819,24 (PubMed=24312454)
24 (PubMed=25010205)
D3S135817 (PubMed=25010205)
17,18 (PubMed=24312454)
D5S81810,13 (PubMed=24312454)
13 (PubMed=25010205)
D7S8208,9
D8S117913,14
D13S3178,11
D16S5399
D18S5112 (PubMed=25010205)
12,14 (PubMed=24312454)
D19S43314 (PubMed=25010205)
14,14.2 (PubMed=24312454)
D21S1129,30
FGA19 (PubMed=25010205)
19,21 (PubMed=24312454)
TH016,7 (PubMed=24312454)
7 (PubMed=25010205)
TPOX8,11 (PubMed=24312454)
11 (PubMed=25010205)
vWA18 (PubMed=25010205)
18,20 (PubMed=24312454)

Run an STR similarity search on this cell line
Web pages https://www.cccells.org/tables/Ewings.php
https://tcpaportal.org/mclp/
Publications

PubMed=24312454; DOI=10.1371/journal.pone.0080060
May W.A., Grigoryan R.S., Keshelava N., Cabral D.J., Christensen L.L., Jenabi J., Ji L.-Y., Triche T.J., Lawlor E.R., Reynolds C.P.
Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines.
PLoS ONE 8:E80060-E80060(2013)

PubMed=25010205; DOI=10.1371/journal.pgen.1004475
Brohl A.S., Solomon D.A., Chang W., Wang J.-J., Song Y., Sindiri S., Patidar R., Hurd L., Chen L., Shern J.F., Liao H.-L., Wen X.-Y., Gerard J., Kim J.-S., Lopez Guerrero J.A., Machado I., Wai D.H., Picci P., Triche T.J., Horvai A.E., Miettinen M.M., Wei J.S., Catchpoole D., Llombart-Bosch A., Waldman T., Khan J.
The genomic landscape of the Ewing sarcoma family of tumors reveals recurrent STAG2 mutation.
PLoS Genet. 10:E1004475-E1004475(2014)

PubMed=26351324; DOI=10.1158/1535-7163.MCT-15-0074
Teicher B.A., Polley E.C., Kunkel M., Evans D., Silvers T.E., Delosh R.M., Laudeman J., Ogle C., Reinhart R., Selby M., Connelly J., Harris E., Monks A., Morris J.
Sarcoma cell line screen of oncology drugs and investigational agents identifies patterns associated with gene and microRNA expression.
Mol. Cancer Ther. 14:2452-2462(2015)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

DOI=10.5282/edoc.27750
Orth M.F.
Systematic multi-omics profiling of Ewing sarcoma cell lines.
Thesis PhD (2021), Ludwig Maximilians University of Munich, Germany

Cross-references
Cell line databases/resources cancercelllines; CVCL_M153
Cell_Model_Passport; SIDM01486
DepMap; ACH-001038
Encyclopedic resources Wikidata; Q54813968
Gene expression databases GEO; GSM1676350
GEO; GSM1701627
Polymorphism and mutation databases Cosmic; 2228219
Entry history
Entry creation06-May-2013
Last entry update05-Oct-2023
Version number20